PPD CorEvitas Psoriasis Registry

CorEvitas is a premier provider of real-world evidence (RWE) and clinical data intelligence, specializing in longitudinal registries for autoimmune and inflammatory diseases. The company manages several large-scale registries, including the Psoriasis Registry, which collect deep clinical data from both providers and patients to support drug safety, comparative effectiveness, and regulatory requirements. Following its acquisition by PPD (part of Thermo Fisher Scientific) in 2023, CorEvitas integrates its data capabilities with global clinical research services. Its datasets are widely used by pharmaceutical companies to gain insights into long-term patient outcomes and treatment patterns in real-world settings. The company's evidence platform combines clinical data with patient-reported outcomes and bio-sample data to provide a holistic view of the patient journey.